Swine flu vaccine development efforts hastened worldwide following alert from WHOJune 3rd, 2009 - 11:25 am ICT by ANI
Washington, June 3 (ANI): Having issued an alert that a pandemic may be imminent, the World Health Organization (WHO) has prompted scientists worldwide to accelerate their efforts to develop a swine flu as early as possible.
“It can take five or six months to come up with an entirely novel influenza vaccine. There is a great deal of hope that biotech and pharma companies might be able to have something ready sooner,” says John Sterling, the Editor-in-Chief of Genetic Engineering and Biotechnology News (GEN).
Officials at a company called Replikins, which actually predicted over a year ago that significant outbreaks of the H1N1 flu virus would occur within 6-12 months, say that their PanFLu vaccine is ready for clinical trials.
Novavax plans to create a virus-like particle-based (VLP) vaccine against the H1N1 strain, which obviates the need for a live virus seed for manufacturing.
The VLPs contain the proteins that make the virus’ outer shell and the surface proteins, without the RNA required for replication. (ANI)
Tags: biotechnology news, clinical trials, development efforts, flu, flu virus, genetic engineering, influenza, influenza vaccine, john sterling, june 3, outer shell, pandemic, pharma companies, replication, rna, surface proteins, swine flu vaccine, vaccine development, vlps, world health organization